Sage Journals: Discover world-class research

Retricted access

Research article

First published 2004-4

Conversion of Chronic Hemodialysis Patients from Erythropoietin Alfa to Darbepoetin Alfa

Amy Martin-Holohan, Kelley A. Curtis, Patricia Masterson [...]

Hospital Pharmacy

Retricted access

Research article

First published 2005-11

Darbepoetin Alfa Therapeutic Interchange Protocol for Anemia in Dialysis

Donald F Brophy, Elizabeth BD Ripley, Denise R Kockler [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2002-7

Darbepoetin Alfa: A Novel Erythropoiesis-Stimulating Protein

Melanie S Joy

Annals of Pharmacotherapy

Free access

Research article

First published 2010-7

The use of Drotrecogin Alfa in Severe Falciparum Malaria

O. Robak, A. Bojic, G. J. Locker [...]

Anaesthesia and Intensive Care

Retricted access

Research article

First published 2004-9

Efficacy of Epoetin Alfa in a Retrospective Non-stratified Subgroup Analysis of a Breast Cancer Cohort Receiving Non-platinum Chemotherapy

Emilio Bajetta, Els Vercammen, Uwe Reinhardt [...]

Tumori Journal

Retricted access

Case report

First published 2004-3

Hypocalcemia and Azotemia Associated with Zoledronic Acid and Interferon Alfa

Tawee Tanvetyanon, Abdul M Choudhury

Annals of Pharmacotherapy

Open access

Brief report

First published 2024-03-05

Post-hoc Nonparametric Analysis of Forced Vital Capacity in the COMET Trial Demonstrates Superiority of Avalglucosidase Alfa vs Alglucosidase Alfa

Matthias Boentert, Emmanuelle Salort Campana, Shahram Attarian [...]

Journal of Neuromuscular Diseases

Retricted access

Research article

First published 2019-1

Real-world utilization of darbepoetin alfa in cancer chemotherapy patients

Xiaoyun (Lucy) Pan, Beth L Nordstrom, Sharon MacLachlan [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2014-8

Dornase Alfa for Non–Cystic Fibrosis Pediatric Pulmonary Atelectasis

Krisy-Ann Thornby, Ashley Johnson, Samantha Axtell

Annals of Pharmacotherapy

Retricted access

Review article

First published 2019-9

Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent

Jason Powell, James Taylor, Scott G. Garland

Annals of Pharmacotherapy

Search results